Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:BTTXNASDAQ:KDLYNASDAQ:REUNNYSE:UPHL On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBTTXBetter Therapeutics$0.00$0.00$0.00▼$0.03$5K0.9517,023 shs100 shsKDLYKindly MD$14.22+2.0%$11.50$0.65▼$34.77$85.63MN/A2.09 million shs905,329 shsREUNReunion Neuroscience$1.12$1.12$0.63▼$5.07$13.13M2.29210,209 shsN/AUPHLUpHealth$0.00$0.00$0.00▼$0.51$4K0.857,490 shs236 shs5G Stocks: The Path Forward is ProfitableEnter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBTTXBetter Therapeutics0.00%0.00%0.00%-75.00%-98.51%KDLYKindly MD0.00%+3.04%-40.45%+552.29%+385.32%REUNReunion Neuroscience0.00%0.00%0.00%0.00%0.00%UPHLUpHealth0.00%0.00%-33.33%0.00%-99.95%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationBTTXBetter TherapeuticsN/AN/AN/AN/AN/AN/AN/AN/AKDLYKindly MDN/AN/AN/AN/AN/AN/AN/AN/AREUNReunion NeuroscienceN/AN/AN/AN/AN/AN/AN/AN/AUPHLUpHealthN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBTTXBetter Therapeutics 0.00N/AN/AN/AKDLYKindly MD 0.00N/AN/AN/AREUNReunion Neuroscience 0.00N/AN/AN/AUPHLUpHealth 0.00N/AN/AN/ACompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBTTXBetter TherapeuticsN/AN/AN/AN/AN/AN/AKDLYKindly MD$2.47M34.66N/AN/AN/A∞REUNReunion Neuroscience$3.88M3.38N/AN/A$1.37 per share0.82UPHLUpHealth$130M0.00N/AN/A$3.10 per share0.00Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBTTXBetter Therapeutics-$39.76MN/A0.00∞N/AN/AN/AN/A7/21/2025 (Estimated)KDLYKindly MDN/A-$0.77N/A∞N/AN/AN/AN/AN/AREUNReunion Neuroscience-$36.69MN/A0.00N/AN/AN/A-91.82%-64.58%N/AUPHLUpHealth-$56.42M-$1.35N/A∞N/AN/AN/AN/AN/ALatest REUN, BTTX, UPHL, and KDLY EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/8/2025Q1 2025KDLYKindly MDN/A-$0.17N/A-$0.17N/AN/A3/28/2025Q4 2024KDLYKindly MDN/A-$0.17N/A-$0.17N/A$0.60 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthBTTXBetter TherapeuticsN/AN/AN/AN/AN/AKDLYKindly MDN/AN/AN/AN/AN/AREUNReunion NeuroscienceN/AN/AN/AN/AN/AUPHLUpHealthN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioBTTXBetter TherapeuticsN/AN/AN/AKDLYKindly MDN/A5.435.42REUNReunion NeuroscienceN/A3.513.51UPHLUpHealthN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipBTTXBetter Therapeutics34.00%KDLYKindly MDN/AREUNReunion Neuroscience12.88%UPHLUpHealth56.10%Insider OwnershipCompanyInsider OwnershipBTTXBetter Therapeutics51.40%KDLYKindly MD50.50%REUNReunion NeuroscienceN/AUPHLUpHealth34.24%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableBTTXBetter Therapeutics4049.86 million24.23 millionOptionableKDLYKindly MDN/A6.02 million2.96 millionN/AREUNReunion Neuroscience1611.72 millionN/ANot OptionableUPHLUpHealth1,75018.93 million12.45 millionNo DataREUN, BTTX, UPHL, and KDLY HeadlinesRecent News About These CompaniesUpHealth, Inc. (UPHL) Latest Stock News & Headlines - Yahoo FinanceApril 24, 2025 | finance.yahoo.comLemon Dump Cake RecipeSeptember 9, 2024 | msn.comDJUSIV Dow Jones US Business Support Services IndexJuly 27, 2024 | seekingalpha.comUpHealth Inc Ordinary Shares UPHLJuly 19, 2024 | morningstar.comUpHealth Holdings, Inc. Wins Ruling in Calcutta High Court, Mandating All Glocal Healthcare Respondents Submit Affidavits of AssetsMay 24, 2024 | prnewswire.comUpHealth, Inc. (UPHL) Advances While Market Declines: Some Information for InvestorsApril 30, 2024 | zacks.comUpHealth, Inc. (UPHL)April 17, 2024 | finance.yahoo.comCalcutta High Court rules in favour of UpHealth Holdings, Inc., and vigorously reinforces the ICC International Court of Arbitration previous $110 million award against Glocal directors and other Respondents, calling their conduct “dishonest and fraudulent”April 16, 2024 | finance.yahoo.comUpHealth Holdings Takes Steps to Enforce the International Court of Arbitration’s Final Award to UpHealth Holdings of more than $110 Million in Damages in Breach of Contract Lawsuit Involving the 2020 Purchase by UpHealth of Glocal Healthcare SystemsApril 1, 2024 | finance.yahoo.comUpHealth, Inc.: UpHealth Provides Corporate Update and Announces Fourth Quarter and Full Year 2023 Financial ResultsMarch 22, 2024 | finanznachrichten.deUpHealth Provides Corporate Update and Announces Fourth Quarter and Full Year 2023 Financial ResultsMarch 21, 2024 | finance.yahoo.comHealthcare Triangle GAAP EPS of -$1.26, revenue of $7.1MMarch 18, 2024 | msn.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeREUN, BTTX, UPHL, and KDLY Company DescriptionsBetter Therapeutics NASDAQ:BTTX$0.0001 0.00 (0.00%) As of 10:20 AM EasternBetter Therapeutics, Inc., a prescription digital therapeutics company, develops a form of cognitive behavioral therapy to address the causes of cardiometabolic diseases. The company's lead product candidate is BT-001, an investigational PDT platform to treat type 2 diabetes. It also develops software-based prescription digital therapeutics platform candidates for treating diabetes, heart disease, and other cardiometabolic conditions. In addition, the company's clinical development candidates are intended to treat cardiometabolic diseases, including type 2 diabetes, hypertension, hyperlipidemia, non-alcoholic fatty liver disease, non-alcoholic steatohepatitis, and chronic kidney disease. Its product pipeline also includes BT-002, which intends glycemic control for hypertension; BT-003 to reduce LDL cholesterol in patients with hyperlipidemia; and BT-004, which intends to explore the impact of treatment on liver health in patients with non-alcoholic steatohepatitis/non-alcoholic fatty liver disease. The company was founded in 2015 and is headquartered in San Francisco, California.Kindly MD NASDAQ:KDLY$14.22 +0.28 (+2.01%) As of 06/20/2025Kindly MD, Inc. provides healthcare services. Its services include medication management, behavioral healthcare and alternative treatments. The firm offers evaluation and management, including chronic pain, functional medicine, cognitive behavioral therapy, trauma and addiction therapy, recovery support services, overdose education efforts, peer support, limited urgent care, preventative medicine, travel services, and hormone therapy. The company was founded by Timothy Pickett in December 2019 and is headquartered in Murray, UT.Reunion Neuroscience NASDAQ:REUNReunion Neuroscience Inc., a clinical-stage biopharmaceutical company, develops therapeutic solutions for mental health conditions in North America. The company's lead asset includes RE104, a clinical-stage serotonergic psychedelic therapeutic product for antidepressant applications. It is also developing the RE200 series, which comprises molecules that are structurally designed to be similar to classical psychedelics with selective potency at the target serotonin 2A receptor (5HT2A) for potential chronic treatment in various patient populations and indications. The company was formerly known as Field Trip Health Ltd. Reunion Neuroscience Inc. was founded in 2008 and is headquartered in Toronto, Canada.UpHealth NYSE:UPHL$0.0002 0.00 (0.00%) As of 06/20/2025 12:33 PM EasternUpHealth, Inc. provides behavioral health solutions through the utilization of evidence-based treatments and services in the Americas. The company offers mental health and substance use disorder treatment services directly to consumers. It also provides detoxification, residential, partial hospitalization program, intensive outpatient program, outpatient services, and non-clinical recovery residence and supporting housing services. UpHealth, Inc. is headquartered in Delray Beach, Florida. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Microsoft Stock Holds Steady as AI Drives Workforce Shift Top International ETFs With Dividends and Market-Beating Returns D-Wave Goes International With South Korea Partnership BigBear.ai Poised to Benefit as Palantir Dominates AI Defense Kroger Stock Confirms Buy Signal as Uptrend Gains Strength Darden Stock Set to Sizzle After Blowout Q4 and $1B Buyback Alphabet’s Comeback: The Hidden Engines Powering Google New All-Time Highs Coming for Broadcom? Wall Street Says Yes Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
